Skip to content
10-Q

Quarterly Report

PREMIER BIOMEDICAL INC

0001654954-19-013012

← back to feed
Filed
Nov 14, 2019 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2019 · Nov 12, 2019 186.96M sh
Shares Diluted Q3 2019 · Sep 30, 2019 26.82M sh
Shares Diluted Q3 2019 · Sep 30, 2019 14.84M sh
Shares Diluted Q3 2019 · Sep 30, 2018 3.31M sh
Shares Diluted Q3 2019 · Sep 30, 2018 3.07M sh
Capex Q3 2019 · Sep 30, 2019 $4.85K
Capex Q3 2019 · Sep 30, 2018 $2.03K
Operating Cash Flow Q3 2019 · Sep 30, 2019 −$273.17K
Operating Cash Flow Q3 2019 · Sep 30, 2018 −$318.47K
Stockholders Equity Q3 2019 · Sep 30, 2019 −$2.12M
Stockholders Equity Q3 2019 · Jun 30, 2019 −$2.14M
Stockholders Equity Q3 2019 · Mar 31, 2019 −$1.97M
Stockholders Equity Q3 2019 · Dec 31, 2018 −$2.15M
Stockholders Equity Q3 2019 · Sep 30, 2018 −$2.24M
Stockholders Equity Q3 2019 · Jun 30, 2018 −$2.03M
Stockholders Equity Q3 2019 · Mar 31, 2018 −$1.93M
Stockholders Equity Q3 2019 · Dec 31, 2017 −$2.61M
Current Liabilities Q3 2019 · Sep 30, 2019 $2.3M
Current Liabilities Q3 2019 · Dec 31, 2018 $2.31M
Total Liabilities Q3 2019 · Sep 30, 2019 $2.3M
Total Liabilities Q3 2019 · Dec 31, 2018 $2.31M
Current Assets Q3 2019 · Sep 30, 2019 $177.58K
Current Assets Q3 2019 · Dec 31, 2018 $159.79K
Total Assets Q3 2019 · Sep 30, 2019 $185.5K
Total Assets Q3 2019 · Dec 31, 2018 $164.99K
Eps Diluted Q3 2019 · Sep 30, 2019 −$0.01
Eps Diluted Q3 2019 · Sep 30, 2019 −$0.02
Eps Diluted Q3 2019 · Sep 30, 2018 −$0.11
Eps Diluted Q3 2019 · Sep 30, 2018 $0.03
Eps Basic Q3 2019 · Sep 30, 2019 −$0.01
Eps Basic Q3 2019 · Sep 30, 2019 −$0.02
Eps Basic Q3 2019 · Sep 30, 2018 −$0.11
Eps Basic Q3 2019 · Sep 30, 2018 $0.03
Sga Expense Q3 2019 · Sep 30, 2019 $36.76K
Sga Expense Q3 2019 · Sep 30, 2019 $138.59K
Sga Expense Q3 2019 · Sep 30, 2018 $62.57K
Sga Expense Q3 2019 · Sep 30, 2018 $139.88K
Net Income Q3 2019 · Sep 30, 2019 −$181.63K
Net Income Q3 2019 · Sep 30, 2019 −$340.17K
Net Income Q3 2019 · Jun 30, 2019 −$227.05K
Net Income Q3 2019 · Mar 31, 2019 $68.51K
Net Income Q3 2019 · Dec 31, 2018 −$501.67K
Net Income Q3 2019 · Sep 30, 2018 −$363.54K
Net Income Q3 2019 · Sep 30, 2018 $102.78K
Net Income Q3 2019 · Jun 30, 2018 −$100.01K
Net Income Q3 2019 · Mar 31, 2018 $566.32K
Operating Income Q3 2019 · Sep 30, 2019 −$64.55K
Operating Income Q3 2019 · Sep 30, 2019 −$219.69K
Operating Income Q3 2019 · Sep 30, 2018 −$81.33K
Operating Income Q3 2019 · Sep 30, 2018 −$230.7K
Gross Profit Q3 2019 · Sep 30, 2019 $1.81K
Gross Profit Q3 2019 · Sep 30, 2019 $7.51K
Gross Profit Q3 2019 · Sep 30, 2018 $3.85K
Gross Profit Q3 2019 · Sep 30, 2018 $10.13K
Cost Of Revenue Q3 2019 · Sep 30, 2019 $1.65K
Cost Of Revenue Q3 2019 · Sep 30, 2019 $5.47K
Cost Of Revenue Q3 2019 · Sep 30, 2018 $4.37K
Cost Of Revenue Q3 2019 · Sep 30, 2018 $20.58K
Revenue Q3 2019 · Sep 30, 2019 $3.47K
Revenue Q3 2019 · Sep 30, 2019 $12.98K
Revenue Q3 2019 · Sep 30, 2018 $8.23K
Revenue Q3 2019 · Sep 30, 2018 $30.71K
Cash And Equivalents Q3 2019 · Dec 31, 2018 $86.83K
Cash And Equivalents Q3 2019 · Dec 31, 2017 $83.7K